179 related articles for article (PubMed ID: 36945831)
1.
Liang F; Dong Z; Ye J; Hu W; Bhandari RK; Mai K; Wang X
Epigenetics; 2023 Dec; 18(1):2192326. PubMed ID: 36945831
[TBL] [Abstract][Full Text] [Related]
2. Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.
Morita S; Horii T; Hatada I
Methods Mol Biol; 2018; 1767():419-428. PubMed ID: 29524149
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
[TBL] [Abstract][Full Text] [Related]
5. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
Lau CH; Suh Y
Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
[TBL] [Abstract][Full Text] [Related]
6. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.
Kabadi AM; Machlin L; Dalal N; Lee RE; McDowell I; Shah NN; Drowley L; Randell SH; Reddy TE
J Cyst Fibros; 2022 Jan; 21(1):164-171. PubMed ID: 34049825
[TBL] [Abstract][Full Text] [Related]
7. Allele-Specific Epigenome Editing.
Bashtrykov P; Jeltsch A
Methods Mol Biol; 2018; 1767():137-146. PubMed ID: 29524132
[TBL] [Abstract][Full Text] [Related]
8. Harnessing targeted DNA methylation and demethylation using dCas9.
Pflueger C; Swain T; Lister R
Essays Biochem; 2019 Dec; 63(6):813-825. PubMed ID: 31724704
[TBL] [Abstract][Full Text] [Related]
9. Epigenome editing for targeted DNA (de)methylation: a new perspective in modulating gene expression.
Seem K; Kaur S; Kumar S; Mohapatra T
Crit Rev Biochem Mol Biol; 2024; 59(1-2):69-98. PubMed ID: 38440883
[TBL] [Abstract][Full Text] [Related]
10. Concurrent genome and epigenome editing by CRISPR-mediated sequence replacement.
Alexander J; Findlay GM; Kircher M; Shendure J
BMC Biol; 2019 Nov; 17(1):90. PubMed ID: 31739790
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas mediated epigenome editing for cancer therapy.
Ansari I; Chaturvedi A; Chitkara D; Singh S
Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
[TBL] [Abstract][Full Text] [Related]
12. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
[TBL] [Abstract][Full Text] [Related]
13. Efficient Targeted DNA Methylation with dCas9-Coupled DNMT3A-DNMT3L Methyltransferase.
Bashtrykov P; Rajaram N; Jeltsch A
Methods Mol Biol; 2023; 2577():177-188. PubMed ID: 36173573
[TBL] [Abstract][Full Text] [Related]
14. Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing.
Hanzawa N; Hashimoto K; Yuan X; Kawahori K; Tsujimoto K; Hamaguchi M; Tanaka T; Nagaoka Y; Nishina H; Morita S; Hatada I; Yamada T; Ogawa Y
Sci Rep; 2020 Mar; 10(1):5181. PubMed ID: 32198422
[TBL] [Abstract][Full Text] [Related]
15. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Gene Expression Using dCas9-SunTag Platforms.
Morita S; Horii T; Hatada I
Methods Mol Biol; 2023; 2577():189-195. PubMed ID: 36173574
[TBL] [Abstract][Full Text] [Related]
17. Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing.
O'Geen H; Tomkova M; Combs JA; Tilley EK; Segal DJ
Nucleic Acids Res; 2022 Apr; 50(6):3239-3253. PubMed ID: 35234927
[TBL] [Abstract][Full Text] [Related]
18. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish.
Kawahara A; Hisano Y; Ota S; Taimatsu K
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373
[TBL] [Abstract][Full Text] [Related]
19. Generation of Epigenetic Disease Model Mice by Targeted Demethylation of the Epigenome.
Horii T; Morita S; Hatada I
Methods Mol Biol; 2023; 2577():255-268. PubMed ID: 36173579
[TBL] [Abstract][Full Text] [Related]
20. Genomic Targeting of TET Activity for Targeted Demethylation Using CRISPR/Cas9.
Nguyen TV; Lister R
Methods Mol Biol; 2021; 2272():181-194. PubMed ID: 34009614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
